
Eli Lilly and Company (NYSE:LLY) shares are trading lower Friday, among other GLP-1 drug manufacturers, following President Donald Trump‘s comments that fat-loss drugs will be a lot lower in price.
What To Know: In a Thursday press conference, Trump told reporters that popular fat-loss drugs like Eli Lilly's Mounjaro and Novo Nordisk's (NYSE:NVO) Ozempic will see price reductions. The comments sent shares of GLP-1 drugmakers lower in after-hours trading on Thursday.